Poly Medicure Limited (POLYMED) — deviation variation | 10 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
No deviation in QIP fund utilization for Q1 FY26
💡 Investor Takeaway
Shareholders should note there is no material deviation in how QIP proceeds were used, confirming adherence to original fund allocation plans.

Poly Medicure Limited raised Rs 99,999.98 lakh via QIP in August 2024 and reports no deviation in fund utilization for the quarter ended June 30, 2026, as confirmed by its Audit Committee. The funds were allocated to capital expenditure, inorganic initiatives, and general corporate purposes with no material variance from the placement document's stated objects.

📄 View Original Announcement (PDF)

About Poly Medicure Limited (POLYMED)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹15,192.77 Cr P/E: 46.4

View full POLYMED stock details →

📡 Get AI alerts when POLYMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track POLYMED — Free

📊 More POLYMED filings

See all POLYMED filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when POLYMED files new disclosures

Track POLYMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track POLYMED — Free

Free account · 2 AI queries/day